GPA33 and cancer: We quantified co-immunofluorescence of these antigens with GPA33 and found that GPA33-negative cancer cells displayed high levels of nuclear β-catenin, indicating high WNT activity (Fig. 1B), and strong expression of the EMT marker LAMC2 (Fig. 1C).